Neurology News

A study of more than 50,000 children born over a 14-year period in Denmark found that children born to mothers who were exposed to higher levels of lithium in their drinking water were moderately more likely to develop autism.

Vico Therapeutics announced that the first patient has been dosed in a phase 1/2a study evaluating VO659, an investigational antisense oligonucleotide for Huntington’s disease and spinocerebellar ataxia types 1 and 3.

Symptoms of sleep disturbance, including long or short duration, impaired quality and difficulty getting to or maintaining sleep, were significantly associated with increased odds of stroke, according to research presented in Neurology.

A modified Mediterranean ketogenic diet was associated with changes in a biological pathway linked to Alzheimer’s disease among older adults with mild cognitive impairment, according to study results published in Alzheimer’s and Dementia.

The descendants of Estée Lauder donated $200 million to the Alzheimer’s Drug Discovery Foundation to help prevent, diagnose, treat and cure the disease, according to a press release.

Nearly half of people living with mood disorders such as anxiety and depression after stroke did not receive mental health treatment, and those being treated tend to only receive medication, researchers reported.

The FDA approval of Zavzpret, which Pfizer announced in March 2023, is good news for people living with migraine, as it becomes an important option to help combat this disease.

Biogen Inc. has reported promising data from a phase 1b trial of BIIB080, an investigational antisense oligonucleotide therapy that reduced soluble tau protein in cerebrospinal fluid in patients with early Alzheimer’s disease.

Astrocyte Pharmaceuticals Inc. announced initiation of a phase 1b study of AST-004, a small molecule adenosine A3/A1 receptor agonist for stroke and traumatic brain injuries that will be evaluated in healthy volunteers.

Speed of processing training reduced the risk for future falls over 10 years in high-risk older adults, while reasoning and memory training did not reduce the likelihood of future falls in this population, according to research.